Received: 31 August 2020
Accepted: 14 September 2020
First Online: 21 September 2020
Ethics approval and consent to participate
: The study was approved by the research ethics committee of Sorbonne University (CER-SU N°2020-48) and information was given to the patients or their relatives.
: Not applicable
: Dr. SIMILOWSKI reports personal fees from ADEP Assistance, AstraZeneca France, Boerhinger Ingelheim France, Chiesi France, GSK France, Lungpacer Inc., Novartis France, and TEVA France, outside the submitted work. In addition, Dr. Similowski has a patent titled “brain-ventilator interface” licensed to Air Liquide Medical Systems and MyBrainTechnology, a patent for a “protection device for intubation” pending, and a patent for a “non-contact thoracic movement imaging system” pending.Alexandre Demoule reports personal fees from Medtronic, grants, personal fees and non-financial support from Philips, personal fees from Baxter, personal fees from Hamilton, personal fees and non-financial support from Fisher & Paykel, grants from French Ministry of Health, personal fees from Getinge, grants and personal fees from Respinor, and grants and non-financial support from Lungpacer, outside the submitted work.Martin Dres received personal fees and travel expenses from Lungpacer outside the submitted work.The other authors had no conflict of interest to declare.